About the Company
vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VNDA News
Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia
Shares of Vanda Pharmaceuticals Inc. VNDA were down 5.6% on Mar 6 after the company announced that the FDA issued a complete ...
Chairman of Vanda Pharmaceuticals Inc (VNDA) Sells Shares
Mihael Polymeropoulos, Chairman of the Board of Vanda Pharmaceuticals Inc (NASDAQ:VNDA), executed a sale of 55,172 shares in ...
Vanda Pharmaceuticals Inc VNDA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Corporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc. 202-734-3400 pr@vandapharma.com View original content to download multimedia ...
Vanda Pharmaceuticals (NASDAQ: VNDA)
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis ...
Vanda Pharmaceuticals Receives CRL From FDA On SNDA For HETLIOZ - Quick Facts
Vanda Pharmaceuticals Inc. (VNDA) has received a Complete Response Letter from the FDA as part of ongoing review of supplemental New ...
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis ...
Vanda Pharmaceuticals Inc VNDA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Vanda Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...